Rabeprazole (API)

Anti-UlcerantAPI

Benzoimidazole-class PPI API manufactured under WHO-GMP. Offers low related substances and is optimised for rapid conversion to enteric pellets or tablets.

  • GradeIP / BP / USP / EP
  • Pack Size25/50 kg
  • CertificationsWHO-GMP • ISO 9001

Product overview

Rabeprazole Sodium EC pellets offer the sodium salt’s fast onset in a gastro-resistant multiparticulate format. Rraynex processes the active under controlled conditions to prevent oxidative degradation, then applies seal and enteric coats that preserve potency while ensuring timed intestinal release. Pellets achieve tight particle size distribution, promoting uniform flow through capsule fillers and compatibility with sachet presentations. Continuous analytics track assay, moisture, and dissolution to maintain consistent acid suppression performance. Customers receive comprehensive technical data, including dissolution comparisons, impurity profiles, and stability results across ICH zones. Packaging configurations such as moisture-resistant drums, nitrogen-flushed bags, or pilot-scale packs accommodate diverse commercial needs. Our technical experts guide blend optimization, lubricant choices, and regulatory documentation preparation. With proactive change-control communication and audit-ready files, Rraynex supports dependable rabeprazole sodium supply for global markets.

Technical specifications

Grade
IP / BP / USP / EP
Type
API
Category
Anti-Ulcerant
Pack size
25/50 kg
Available strengths
Custom / On request
Certifications
WHO-GMP, ISO 9001, ISO 14001

Frequently asked questions